Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Novartis
Dow
Julphar
Chinese Patent Office
Baxter
Queensland Health
McKesson
Deloitte
Harvard Business School

Generated: February 24, 2018

DrugPatentWatch Database Preview

Sciegen Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?

SCIEGEN PHARMS INC has twenty-four approved drugs.

There is one tentative approval on SCIEGEN PHARMS INC drugs.

Summary for Sciegen Pharms Inc
US Patents:0
Tradenames:22
Ingredients:21
NDAs:24

Drugs and US Patents for Sciegen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 203855-006 Oct 28, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 209635-001 Nov 29, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc IRBESARTAN irbesartan TABLET;ORAL 204774-001 Dec 7, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 203855-004 Oct 28, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 205794-002 Mar 1, 2016 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc GABAPENTIN gabapentin CAPSULE;ORAL 204989-003 Feb 18, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc LAMOTRIGINE lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 206382-002 Jun 17, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 205794-001 Mar 1, 2016 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 204597-002 Mar 16, 2015 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 209635-002 Nov 29, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Argus Health
Deloitte
Moodys
Dow
Harvard Business School
Colorcon
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot